17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib
Rainer Girgert(University of Göttingen), Carsten Gründker(Universitätsmedizin Göttingen)
Cited by 36
Related Papers
Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells
|Cancer Genomics & Proteomics|2023|16
Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple‑negative breast cancer by 17β‑estradiol
|Oncology Letters|2018|10
G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of<i>SERPINE1</i>/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells<i>In Vitro</i>
|Cancer Genomics & Proteomics|2024|3
G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects Aggressiveness of Cervical Carcinoma Cells Depending on Histological Entity
|Cancer Genomics & Proteomics|2025|3